2020 Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials

Antonio Galvano; Dalila Scaturro; Antonio Russo; Viviana Bazan; Giulia Letizia Mauro

2020 Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials

Antonio Galvano, Dalila Scaturro, Antonio Russo, Viviana Bazan, Giulia Letizia Mauro

Risultato della ricerca: Letter › peer review

Lingua originale	English
Numero di pagine	1
Rivista	Journal of Bone Oncology
Stato di pubblicazione	Published - 2020

All Science Journal Classification (ASJC) codes

Oncology

Altri file e collegamenti

OA Link

Cita questo

@article{52f3b6c33a864f428f25e4c412fbf4ae,

title = "2020 Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials",

author = "Antonio Galvano and Dalila Scaturro and Antonio Russo and Viviana Bazan and {Letizia Mauro}, Giulia",

year = "2020",

language = "English",

journal = "Journal of Bone Oncology",

issn = "2212-1374",

publisher = "Elsevier GmbH",

}

TY - JOUR

T1 - 2020 Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials

AU - Galvano, Antonio

AU - Scaturro, Dalila

AU - Russo, Antonio

AU - Bazan, Viviana

AU - Letizia Mauro, Giulia

PY - 2020

Y1 - 2020

UR - http://hdl.handle.net/10447/423059

M3 - Letter

JO - Journal of Bone Oncology

JF - Journal of Bone Oncology

SN - 2212-1374

ER -